Bottle Caps Biddings - Procurement Opportunities

The solicitation is for the procurement of acyclovir capsules, with a base year and four one-year options. Offerors must submit a price for all line items and option years. The offer must include a 0. 5 cost recovery fee. Offerors must list an 11-digit NDC number for each drug. A letter of commitment from the manufacturer is required if the offeror is not the manufacturer. The contract will be effective on the date the contracting officer signs the **** and notifies the offeror. The implementation period is the timeframe beginning on the contract effective date and ending at the start of the ordering period. The ordering period begins at the expiration of the implementation period. The contract will be in effect for the duration of the implementation period plus one year ordering period with four one-year pre-priced option ordering periods. The contractor will receive payments from the prime vendor programs instead of directly from the government. Product registration with the FDA is required within 5 calendar days of contract award. The government reserves the right to inspect records pertaining to sales under the contract. The contractor shall report all contract sales by calendar quarter and submit collected cost recovery fees. The cost recovery fee is 0. 5 of the current contract price. The contractor shall use only FDA-inspected manufacturing facilities. The contract is subject to the Drug Supply Chain Security Act (DSCSA) requirements. The offerors representations and certifications, including those completed electronically via the System for Award Management (SAM), are incorporated by reference into the contract.

The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for dextroamphetamine amphetamine ER capsules. This will be a firm fixed price, requirements type contract with a one-year base and four one-year options. Interested parties should contact Nancy Fernandez for any questions or comments and set up automated notifications of pre-solicitation or solicitation changes through the DLA bid board system (DIBBS) and SAM. gov. The current projected solicitation date is April 2025, but the DLA reserves the right to issue the solicitation before or after this date. Annual usage estimates will be provided in the schedule of supplies section of the solicitation.

This is a combined synopsis/solicitation for commercial items. Quotes are requested, and a written solicitation will not be issued. The solicitation is for 2 each 1 **** PortaCount model **** 115v generator respirator fit tester. All firms or individuals responding must be registered with the System for Award Management (SAM). This requirement is a 100% small business set-aside. Offers from firms not meeting this requirement will not be considered. The vendor must be an original equipment manufacturer (OEM) authorized dealer, authorized distributor, or authorized reseller. OEM warranty and service must be provided and maintained by the OEM. Quotes must include all aspects of the RFQ, including all equipment, services, and options. The delivery location is the Phoenix Indian Medical Center, **** N. 16th Bldg 9, Phoenix, AZ **** shall be prepared monthly electronically using the Invoice Processing Platform (IPP). The quote due date is November 4, 2025, 5:00 PM EST. The government intends to award a purchase order to the responsive and responsible vendor whose conforming response is determined to provide the best value to the government, price and other factors considered. The evaluation procedures will be in accordance with FAR 13. 106. The government will select the quote that represents the best benefit to the government at a price that can be determined reasonable. The government will perform a comparative evaluation of technical solution, past performance, and price. Past performance information will be utilized to determine the probability of success relative to the required effort. Relevant past performance evaluation via past performance information retrieval system (PPIRS) records for the identified contract will be assessed and other records within PPIRS may be considered.

The notice describes a contract for the supply of drugs and biologicals (acyclovir capsules). Offerors must submit prices for line items 1 and 2 for the base year and all four option years. One award will be made in the aggregate for all items. The notice specifies the required information to be entered by the contracting officer at the time of contract award.